Format

Send to

Choose Destination
See comment in PubMed Commons below
Int Urol Nephrol. 1990;22(6):561-6.

The effect of sulphinpyrazone and alpha-tocopherol on platelet activation and function in haemodialysed patients.

Author information

1
Department of Haematology and Nephrology, Medical School, Lublin, Poland.

Abstract

In 30 patients on chronic haemodialysis treatment the platelet activity and function were studied before and during antiplatelet therapy with alpha-tocopherol and sulphinpyrazone. In both kinds of treatment a significant decrease of ADP-induced and spontaneous aggregation was observed. Sulphinpyrazone exerts an inhibitory effect not only on platelet aggregation but also on platelet factor 3 and provokes a significant prolongation of the bleeding time.

PMID:
2093696
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center